Navigation Links
Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2
Date:10/18/2007

PALO ALTO, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced that preclinical data from its program to develop novel small molecule kinase inhibitors will be presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics in San Francisco. The presentation, "In Vitro and Vivo Anticancer Activities of Dual Inhibitors of Aurora Kinases and VEGFR2" (Abstract # C206) will be on Thursday, October 25, 2007, at 12:30 pm Pacific time during the session "Small Molecule Therapeutic Agents: Kinase Inhibitors."

Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced drug development candidates are TELCYTA(R), a tumor-activated small molecule product candidate in clinical development for the treatment of advanced ovarian cancer and non-small cell lung cancer; and TELINTRA(TM), which is in clinical development for the treatment of myelodysplastic syndrome. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(TM), which enables the rapid and efficient discovery of small molecule drug candidates. Additional information is available at http://www.telik.com.


'/>"/>
SOURCE Telik, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Telik Reports Positive Data Demonstrating Synergy in Combination and Highly Statistically Significant Effect of Telcyta as Maintenance Therapy in First-Line Non-Small Cell Lung Cancer
2. Telik Announces Telcyta Clinical and Preclinical Presentations at AACR Meeting
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Increasing sophistication among enterprise buyers of ... purchasing in 2015, says Moravia CMO, ... study by market research firm Common Sense Advisory, 15 ... their translation and localization needs. "From a language industry ...
(Date:1/22/2015)... 22, 2015 Research and Markets ( ... "Microbiology Testing/Clinical Microbiology Market by Product, Clinical ... 2019" report to their offering. ... techniques for the detection of infectious diseases. The ...
(Date:1/22/2015)... , Jan. 22, 2015 The Parenteral Drug Association (PDA) ... SM : Enabling Pharmaceutical Manufacturing,s Future. ... following goals: , Highlight the ongoing focus PDA ... build practical solutions by filling known gaps in current manufacturing ...
Breaking Medicine Technology:Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
... June 1, 2011 Claron Technology makes the PROFIT ... Medical imaging software developer Claron Technology, headquartered in Toronto, ... ranking of Canada,s Fastest-Growing Companies by PROFIT Magazine. Ranking ... 200 profiles the country,s most successful growth companies. Published ...
... Select Care Benefits Network, Inc. (SCBN), a professional ... or low-cost medication from Patient Assistance Programs , ... announcement that the company has helped patients receive over ... Additionally, to better fulfill its mission ...
Cached Medicine Technology:Claron Technology Makes the PROFIT 200 List for the Third Consecutive Year 2SCBN Prescription Advocacy Celebrates 30,000th Customer 2
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Thousand of ... Medical Care recalled its GranuFlo and NaturaLyte dialysis concentrates ... underway in U.S. District Court, District of Massachusetts, Bernstein ... 20th, the Court has remanded a case filed by ...
(Date:1/22/2015)... 2015 Joan Lunden, award-winning American journalist, ... the upcoming 32nd Annual Miami Breast Cancer Conference ... Resource®, LLC (PER®) , shares that “a fast-growing, virulent” ... if she had not followed up her clean mammogram ...
(Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... Comprehensive Reform, End to Employer,Insurance System, ... future U.S. economic growth. Today,s employer-based system ... insurance system driven by,cost-conscious consumer choice. Those ... Care for All: Moving Beyond the Employer-Based,Health-Insurance ...
... (FDA) has approved DORIBAX(TM),(doripenem for injection) as ... urinary tract infections, including,pyelonephritis. DORIBAX has demonstrated ... Gram-negative bacteria - including Pseudomonas -- that,cause ... CDC, in the U.S., nearly 2 million ...
... teenagers aged 12-18 claim to have been victims of some ... by the University of Haifa and Ben Gurion University. The ... boys and 76% of the girls reported said that they ... Rachel Lev-Wiesel from the University of Haifa,s School of Social ...
... Winners Announced at Annual ASRM Meeting, ... won Ferring,Pharmaceuticals, national 2007 My Little Miracle ... the births of their ,little miracles,children born ... fertility treatments.,The fourth annual contest celebrated the ...
... - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today announced ... Drug,Administration (FDA),s Formal Dispute Resolution process, appealing the,Agency,s ... received a second Approvable Letter from the FDA ... this year. The Company,firmly believes it has met ...
... Hills, NY (Oct. 15, 2007) -- Experts called on ... reverse one of the most serious public health policy ... United States. Neil Blumberg, M.D. and Joanna M. ... the University of Rochester Medical Center, urged that universal ...
Cached Medicine News:Health News:Quality, Affordable Health Care for All 2Health News:Quality, Affordable Health Care for All 3Health News:Quality, Affordable Health Care for All 4Health News:Quality, Affordable Health Care for All 5Health News:MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections 2Health News:Almost 90 percent of children reported experiencing sexual violence 2Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 2Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 4Health News:Labopharm appeals FDA's decision on once-daily tramadol 2Health News:Leukocyte reduction seen as significant advance in transfusion medicine 2Health News:Leukocyte reduction seen as significant advance in transfusion medicine 3
... The Cypress quick test is a rapid ... antibodies to Trypanosoma cruzi. It can ... plasma. The method employs a unique combination ... is conjugated on dye particles, and antigens ...
Silicone ICD lead...
The Livewire steerable electrophysiology catheter is uniquely designed with an ergonomic handle and patented steering mechanism to provide smooth, precise catheter tip movement, even during lengthy e...
... Glaucoma Treatment System will provide ... glaucoma treatments through the use ... (GMS) and DeepLight 790 Titanium ... the eye's natural pressure differential ...
Medicine Products: